Urogen Pharma Ltd (URGN)

EBITDA

-$70.13M

TTM · Period ending: · USD

URGN logo

URGN EBITDA

Latest reported-$70.13M
URGN TTM EBITDA ($1.01M → -$70.13M)
High-resolution chart · PNG

URGN ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-70,126,000
-115,777,000
-135,660,000
-139,724,000
-128,636,000
-109,459,000
-94,347,000
-75,518,000
-73,017,000
-63,266,000
-65,696,000
-82,780,000
-92,594,000
-90,815,000
-91,940,000
-86,877,000
-94,643,000
-102,000,000
-100,357,000
-107,552,000
-106,419,000
-112,276,000
-123,884,000
-135,948,000
-130,710,000
-123,078,000
-108,154,000
-93,391,000
-91,034,000
-85,724,000
-76,754,000
-62,914,000
-42,169,000
-29,650,000
-19,743,000
4,339,000
-1,428,000
1,079,000
1,011,000
-19,899,000
-15,862,000
-13,692,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.